198 related articles for article (PubMed ID: 15226762)
21. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.
Olsen A; Christensen J; Knudsen KE; Johnsen NF; Overvad K; Tjønneland A
Breast Cancer Res Treat; 2011 Aug; 128(3):883-9. PubMed ID: 21340481
[TBL] [Abstract][Full Text] [Related]
22. Serum enterolactone levels and the risk of breast cancer in women with palpable cysts.
Boccardo F; Lunardi G; Guglielmini P; Parodi M; Murialdo R; Schettini G; Rubagotti A
Eur J Cancer; 2004 Jan; 40(1):84-9. PubMed ID: 14687793
[TBL] [Abstract][Full Text] [Related]
23. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
Kyrø C; Hansen L; Frederiksen K; Nørskov NP; Bach Knudsen KE; Eriksen AK; Holm M; Tjønneland A; Olsen A
Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112
[TBL] [Abstract][Full Text] [Related]
24. Prediagnosis plasma concentrations of enterolactone and survival after colorectal cancer: the Danish Diet, Cancer and Health cohort.
Kyrø C; Frederiksen K; Holm M; Nørskov NP; Knudsen KEB; Overvad K; Tjønneland A; Olsen A
Br J Nutr; 2019 Sep; 122(5):552-563. PubMed ID: 30173678
[TBL] [Abstract][Full Text] [Related]
25. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
Guglielmini P; Rubagotti A; Boccardo F
Breast Cancer Res Treat; 2012 Apr; 132(2):661-8. PubMed ID: 22094938
[TBL] [Abstract][Full Text] [Related]
26. Case-control study of phyto-oestrogens and breast cancer.
Ingram D; Sanders K; Kolybaba M; Lopez D
Lancet; 1997 Oct; 350(9083):990-4. PubMed ID: 9329514
[TBL] [Abstract][Full Text] [Related]
27. Dietary lignan intakes and risk of pre- and postmenopausal breast cancer.
McCann SE; Muti P; Vito D; Edge SB; Trevisan M; Freudenheim JL
Int J Cancer; 2004 Sep; 111(3):440-3. PubMed ID: 15221974
[TBL] [Abstract][Full Text] [Related]
28. Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk.
Boccardo F; Lunardi GL; Petti AR; Rubagotti A
Breast Cancer Res Treat; 2003 May; 79(1):17-23. PubMed ID: 12779078
[TBL] [Abstract][Full Text] [Related]
29. Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers.
Kilkkinen A; Erlund I; Virtanen MJ; Alfthan G; Ariniemi K; Virtamo J
Am J Epidemiol; 2006 Apr; 163(8):687-93. PubMed ID: 16510545
[TBL] [Abstract][Full Text] [Related]
30. Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.
Jaskulski S; Jung AY; Rudolph A; Johnson T; Thöne K; Herpel E; Sinn P; Chang-Claude J
Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28734033
[TBL] [Abstract][Full Text] [Related]
31. Premenopausal serum androgens and breast cancer risk: a nested case-control study.
Zeleniuch-Jacquotte A; Afanasyeva Y; Kaaks R; Rinaldi S; Scarmo S; Liu M; Arslan AA; Toniolo P; Shore RE; Koenig KL
Breast Cancer Res; 2012 Feb; 14(1):R32. PubMed ID: 22339988
[TBL] [Abstract][Full Text] [Related]
32. Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies.
Velentzis LS; Cantwell MM; Cardwell C; Keshtgar MR; Leathem AJ; Woodside JV
Br J Cancer; 2009 May; 100(9):1492-8. PubMed ID: 19337250
[TBL] [Abstract][Full Text] [Related]
33. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
[TBL] [Abstract][Full Text] [Related]
34. Determinants of serum enterolactone concentration.
Kilkkinen A; Stumpf K; Pietinen P; Valsta LM; Tapanainen H; Adlercreutz H
Am J Clin Nutr; 2001 Jun; 73(6):1094-100. PubMed ID: 11382665
[TBL] [Abstract][Full Text] [Related]
35. Serum enterolactone concentrations are low in colon but not in rectal cancer patients.
Tuomisto A; Nørskov NP; Sirniö P; Väyrynen JP; Mutt SJ; Klintrup K; Mäkelä J; Bach Knudsen KE; Mäkinen MJ; Herzig KH
Sci Rep; 2019 Aug; 9(1):11209. PubMed ID: 31371751
[TBL] [Abstract][Full Text] [Related]
36. Meta-analyses of lignans and enterolignans in relation to breast cancer risk.
Buck K; Zaineddin AK; Vrieling A; Linseisen J; Chang-Claude J
Am J Clin Nutr; 2010 Jul; 92(1):141-53. PubMed ID: 20463043
[TBL] [Abstract][Full Text] [Related]
37. Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women.
Kim MK; Chung BC; Yu VY; Nam JH; Lee HC; Huh KB; Lim SK
Clin Endocrinol (Oxf); 2002 Mar; 56(3):321-8. PubMed ID: 11940043
[TBL] [Abstract][Full Text] [Related]
38. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
39. Validation of FFQ-based assessment of dietary lignans compared with serum enterolactone in Swedish women.
Lin Y; Wolk A; Håkansson N; Peñalvo JL; Lagergren J; Adlercreutz H; Lu Y
Br J Nutr; 2013 May; 109(10):1873-80. PubMed ID: 23006454
[TBL] [Abstract][Full Text] [Related]
40. Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women.
Aarestrup J; Kyrø C; Knudsen KE; Weiderpass E; Christensen J; Kristensen M; Würtz AM; Johnsen NF; Overvad K; Tjønneland A; Olsen A
Br J Nutr; 2013 Jun; 109(12):2269-75. PubMed ID: 23114205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
